1.2200
-0.0400
(-3.17%)
At close: April 17 at 4:00:02 PM EDT
1.2000
-0.02
(-1.64%)
After hours: April 17 at 7:50:53 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
13,925.6330
10,208.2640
36,022.0690
46,001.4780
Total Liabilities Net Minority Interest
4,617.9870
17,959.1100
7,698.5390
1,506.5140
Total Equity Gross Minority Interest
9,307.6460
-7,750.8460
28,323.5300
44,494.9640
Total Capitalization
9,307.6460
-7,750.8460
28,323.5300
44,494.9640
Common Stock Equity
9,307.6460
-7,750.8460
28,323.5300
44,494.9640
Net Tangible Assets
9,307.6460
-7,750.8460
28,323.5300
44,494.9640
Working Capital
10,044.6460
5,929.1540
28,323.5300
44,494.9640
Invested Capital
9,307.6460
-7,750.8460
28,323.5300
44,494.9640
Tangible Book Value
9,307.6460
-7,750.8460
28,323.5300
44,494.9640
Share Issued
14,236.2310
10,519.9330
8,163.9230
8,100.5700
Ordinary Shares Number
14,236.2310
10,519.9330
8,163.9230
8,100.5700
12/31/2021 - 1/29/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AVXL Anavex Life Sciences Corp.
8.95
+1.24%
SAVA Cassava Sciences, Inc.
1.4400
+2.86%
INMB INmune Bio, Inc.
7.32
+0.14%
ACIU AC Immune SA
1.4800
-1.33%
ANNX Annexon, Inc.
1.4600
+2.10%
CGTX Cognition Therapeutics, Inc.
0.3724
-0.21%
MIST Milestone Pharmaceuticals Inc.
0.8889
+8.80%
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.7824
+10.35%
ALLO Allogene Therapeutics, Inc.
1.4500
+3.57%
ALT Altimmune, Inc.
4.5500
+3.41%